Direct Epidemio-Statistics — Market Access Marketing Expertise

We help SMEs and innovative companies leverage precise data, model and score risks, anticipate adverse events, and create value-driven services.

RC-AVP /Addictions (psychiatrie)
RISK-SCO /Sécurité des Transports
CIR /Agrément 2022-2027
CHRU de Brest
SAMRoute
Ministère de l'enseignement supérieur et de la recherche (Agrément CIR)

Our marketing services

At which stages of market access does Direct Epidemio-Statistics intervene?

/direct epidemio statistics_phases_d_intervention_possible_pour_les_prestations_marketing_acces_marche

What is our value at each stage?

AM-PRE

Feasibility study

Direct Epidemio-Statistics helps you pre-assess market access feasibility. The engagement sizes the study, anticipates risks that may jeopardize approval, and drafts an initial operational schedule. The study may include:

  • a preliminary project sizing
  • a preliminary risk assessment
  • a draft operational schedule
  • a preliminary cost-time estimate (EUR, time)

Engagement elements

  • completed in 2 to 6 weeks
  • PDF deliverable (🇬🇧 / 🇫🇷)
  • on-site presentation
  • email and phone support

Extracts / client cases

/direct epidemio statistics.com_helps_design_a_clinical_trial_on_alcool_consumption_with_the_academic_hospital_of_Brest_in_France.webp

AM-AVP

Protocol design

Direct Epidemio-Statistics helps design the study targeting market authorization and strengthens your argumentation. We intervene on the following topics:

  • choosing the experimental design
  • description of the target population
  • description of variables to collect
  • cohort sizing
  • the epidemiological-statistical analysis plan
  • identification of risks and their costs
  • an ethical assessment of your trial project

Engagement elements

  • completed in 2 to 8 weeks
  • PDF deliverable (🇬🇧 / 🇫🇷)
  • on-site presentation
  • email and phone support

Extracts / client cases

/chru brest table extract.webp

AM-EXE

Cohort follow-up

Direct Epidemio-Statistics helps you track, over the long term, study subjects in your pre-market trials. Our scope may include:

  • design of questionnaires with high response rates
  • sending, collecting, and triaging follow-up mailings
  • coordination of lost-to-follow-up investigations

Engagement elements

  • selection criteria
  • study subject lists
  • follow-up questionnaires
  • feedback from mailings
  • coordination support
  • on-site visits possible
  • email and phone support

Questionnaire example

/direct epidemio statistics_suivi_de_cohorte_sur_le_long_terme_am fol_rc fol.jpg

AM-SYN

Analysis and synthesis

Direct Epidemio-Statistics can perform the epidemiological-statistical analysis, write the methods section, suggest arguments before submission, and help address expert reviews. The scope may include:

  • trial description
  • data pre-processing
  • description of patient profiles
  • choice of statistical inference methods
  • model building and simulations
  • production of tables and charts
  • writing the methods and argument support
  • support for responses to reviewers (methods)

Engagement elements

  • completed in 2 to 12 weeks
  • PDF deliverable (🇬🇧 / 🇫🇷)
  • on-site presentation
  • email and phone support

Extracts / client cases

/direct epidemio statistics_valorisation_des_resultats_de_l_etude_am syn.jpg

AM-MAR

Market access marketing

Direct Epidemio-Statistics helps you develop marketing collateral to promote your results, products, or services. The market access marketing engagement may include:

  • description of your R&D product
  • description of your individual and population profiles
  • production of tables and charts
  • writing the methods and argument support
  • support for responses to technical-sales questions

Engagement elements

  • ongoing / on demand
  • email marketing
  • web page
  • technical documentation
  • white paper
  • bilingual technical writing (🇬🇧 / 🇫🇷)
  • on-site visit possible
  • follow-up by email and phone

Extracts / client cases

/direct epidemio statistics_marketing_acces_marche_exemple_securite_routiere_page_web.jpg